Search

Your search keyword '"McIntosh, Jenny"' showing total 51 results

Search Constraints

Start Over You searched for: Author "McIntosh, Jenny" Remove constraint Author: "McIntosh, Jenny" Database Unpaywall Remove constraint Database: Unpaywall
51 results on '"McIntosh, Jenny"'

Search Results

1. Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapy

2. Adeno-associated virus gene therapy prevents progression of kidney disease in genetic models of nephrotic syndrome

3. Preclinical evaluation of FLT190, a liver-directed AAV gene therapy for Fabry disease

5. The use of a transient transfected expression system to deliver high quality bispecific T-cell engager drug product, NVG-111, to the clinic for a fraction of the cost and time associated with the development and use of a producer cell line.

7. Liver-Directed AAV Gene Therapy for Gaucher Disease

8. Design and Characterization of FLT210, a Potent Next Generation AAV-hFVIII Vector Candidate

9. Liver directed AAV gene therapy to treat Gaucher disease

12. Therapeutic expression of human clotting factors IX and × following adeno‐associated viral vector‐mediated intrauterine gene transfer in early‐gestation fetal macaques

13. A Single Intravenous Infusion of FLT180a Results in Factor IX Activity Levels of More Than 40% and Has the Potential to Provide a Functional Cure for Patients with Haemophilia B

16. GO-8: Preliminary Results of a Phase I/II Dose Escalation Trial of Gene Therapy for Haemophilia a Using a Novel Human Factor VIII Variant

18. Adeno-Associated Mediated Gene Transfer for Hemophilia B:8 Year Follow up and Impact of Removing "Empty Viral Particles" on Safety and Efficacy of Gene Transfer

20. The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins

21. In Utero Transfer of Adeno-Associated Viral Vectors Produces Long-Term Factor IX Levels in a Cynomolgus Macaque Model

23. 171. Production of Therapeutically Relevant Levels of FVIII After Transduction of Lungs With F/HN-Pseudotyped Lentivirus

24. Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B

25. Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant

26. Stable Factor IX Activity Following AAV-Mediated Gene Transfer in Patients with Severe Hemophilia B

27. AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage

28. Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B

29. Adeno-Associated Viral Vector Mediated Gene Transfer for Hemophilia B

30. Stable Human FIX Expression After 0.9G Intrauterine Gene Transfer of Self-complementary Adeno-associated Viral Vector 5 and 8 in Macaques

31. Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical Trial

32. Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins

34. Codon optimization of human factor VIII cDNAs leads to high-level expression

35. Early Clinical Trial Results Following Administration of a Low Dose of a Novel Self Complementary Adeno-Associated Viral Vector Encoding Human Factor IX In Two Subjects with Severe Hemophilia B

38. Genetic Architecture of Tameness in a Rat Model of Animal Domestication

40. Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors

41. Luciferin Detection After Intranasal Vector Delivery Is Improved by Intranasal Rather Than Intraperitoneal Luciferin Administration

42. Luciferin detection after intra-nasal vector delivery is improved by intra-nasal rather than intra-peritoneal luciferin administration.

44. Coating of adeno-associated virus with reactive polymers can ablate virus tropism, enable retargeting and provide resistance to neutralising antisera

45. Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates

47. Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver

Catalog

Books, media, physical & digital resources